Quantitative GLC determination of pentylenetetrazol in biological fluids.
A quantitative, sensitive, and specific GLC method was developed for the determination of pentylenetetrazol in water, plasma, and urine. The assay involves a single extraction of the sample into chloroform followed by centrifugation, evaporation, and chromatography. The method for pentylenetetrazol is reproducible, and the sensitivity limit of the assay is 0.5 mug of pentylenetetrazol/ml of biological fluid using a 2-ml sample. This method has a sensitivty sufficient to detect human plasma levels after therapeutic clinical doses and was successfully applied to monitor complete plasma level profiles of this drug in dogs. The data indicate that this drug is very rapidly absorbed following an oral dose, and the half-life of the drug in plasma is approximately 1 hr.
D000284:Administration, Oral; D000818:Animals; D001826:Body Fluids / Q000032:analysis*; D002849:Chromatography, Gas; D004285:Dogs; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D010433:Pentylenetetrazole / Q000008:administration & dosage / Q000032:analysis* / Q000378:metabolism; D012995:Solubility
D010433:Pentylenetetrazole